1.
Lippert E, Etienne G, Mozziconacci M-J, Laibe S, Gervais C, Girault S, Gachard N, Tigaud I, Dastugue N, Huguet F, Fort M-P, Legros L, Eclache V, Mahon F-X. Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy. Haematologica [Internet]. 2010Aug.31 [cited 2026Nov.17];95(9):1604-7. Available from: https://haematologica.org/article/view/5728